Summary
Spironolactone was used in 90 hirsute women because of its antiandrogenic effect. The drug was administered twice daily from the 4th to the 22nd day of six cycles (total dosage was 200 mg per day). The results suggest that spironolactone is suitable for the treatment of hirsutism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J (1975) Antiandrogenic effects of spironolactones Mechanism of action. Endocrinology 97 52
Cumming DC, Yang JC, Rebar RW, Yen SSC (1982) Treatment of hirsutism with spironolactone. JAMA 247 1295
Eil C, Akelson SK (1984) The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors. J Clin Endocrinol Metab 59 51
Evron S, Shapiro G, Diamant YZ (1981) Induction of ovulation with spironolactone in anovulation oligomenorrheic and hyperandrogenic women. Fertil Steril 36 468
Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21 1440
Hammerstein J, Meckies J, Leo Rossberg L, Zielske F (1975) Use of cyproterone acetate in the treatment of acne, hirsutism and virilism. J Steroid Biochem 6 827
Horton R, Neisler J (1968) Plasma androgens in patients with polycystic ovarian syndrome. J Clin Endocrinol Metab 28 479
Ismail AA, Davidson DW, Sonka RA (1974) The evaluation of the role of androgens in hirsutism and the use of a new antiandrogen cyproterone acetate for therapy. J Clin Endocrinol 39 81
Kirschner MA, Bardin CW, Hembree WC (1970) Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women. J Clin Endocrinol 30 727
Lobo RA, Shoupe D, Serafini P, Brinton D, Horton R (1985) The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril 43 200
Loriaux DL, Menard R, Taylor A, Pita JC, Santen R (1976) Spironolactone and endocrine dysfunction. Annals of Internal Medicine. 85 630
Lumb G, Newberne P, Rust JH, Wagner B (1978) Effect in animals of chronic administration of spironolactone. A review. In Addison GM, Asmussen NW, Corvol P, Kloppenborg PWC, Norman N, Schröder R, Robertson JIC (eds) Aldosterone antagonists in clinical medicine. Excerpta Medica. Amsterdam Oxford, p 132
Mashesh VB, Grenblatt RB, Aydar CK (1964) Urinary steroid excretion patterns in hirsutism. 1. Use of ovarian and adrenal suppression tests in the study of hirsutism. J. Clin Endocrinol 24 1238
Menard RH, Stripp B, Gilette JR (1974) Spironolactone and testicular cytochrome P-450 Decreased testosterone formation in several species and changes in hepatic drug metabolism. Endocrinology 94 1628
Milewicz A, Silber D, Kirschner MA (1983) Therapeutic effects of spironolactone in polycystic ovary syndrome. Obstet Gynecol 61 429
Ober KP, Hennessy JF (1978) Spironolactone therapy for hirsutism in a hyperandrogenic woman. Ann Intern Med 89 643
Rifka SM, Pita JC, Vigerski RA, Wilson YA, Loriaux DL (1978) Interaction of digitalis and spironolactone with human steroid receptors. J Clin Endocrinol Metab 46 338
Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH (1977) Pathophysiology of spironolactone induced gynecomastie. Ann Intern Med 87 398
Shapiro G, Evron S (1980) A novel use of spironolactone Treatment of hirsutism. J Clin Endocrinol Metab 51 429
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Köksal, A., Pabuçcu, R. & Akyürek, C. Spironolactone in the treatment of hirsutism. Arch. Gynecol. 240, 95–100 (1987). https://doi.org/10.1007/BF02134041
Issue Date:
DOI: https://doi.org/10.1007/BF02134041